Hikma Pharmaceuticals Plc Director/PDMR Shareholding (4598O)
May 17 2018 - 8:10AM
UK Regulatory
TIDMHIK
RNS Number : 4598O
Hikma Pharmaceuticals Plc
17 May 2018
Hikma Pharmaceuticals PLC - EIP Vesting
LONDON, 17 May 2018: Hikma Pharmaceuticals PLC (LSE: HIK)
(NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces
that the following Persons Discharging Managerial Responsibility
("PDMR") have received shares as a result of the vesting of their
conditional share awards on 11 May 2016 under the 2014 Executive
Incentive Plan ("EIP") Element B which was completed on 16 May
2018.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities
Hussein Arkhagha
1 Details of the person discharging managerial
responsibilities / person closely associated
--- ---------------------------------------------------------------
a) Name Hussein Arkhagha
--- --------------------- ----------------------------------------
2 Reason for the notification
--- ---------------------------------------------------------------
a) Position/status PDMR
--- --------------------- ----------------------------------------
b) Initial notification Initial notification
/Amendment
--- --------------------- ----------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- ---------------------------------------------------------------
a) Name Hikma Pharmaceuticals PLC
--- --------------------- ----------------------------------------
b) LEI 549300BNS685UXH4JI75
--- --------------------- ----------------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date;
and (iv) each place where transactions have
been conducted
--- ---------------------------------------------------------------
a) Description Description: Ordinary shares of 10
of the financial pence each (Shares)
instrument, ID Code: GB00B0LCW083
type of instrument
and identification
code
--- --------------------- ----------------------------------------
b) Nature of Shares acquired from vesting of the
the transaction conditional awards on
16 May 2018 under the 2014 EIP Element
B.
--- --------------------- ----------------------------------------
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 7,749
--- --------------------- ----------------------------------------
d) Aggregated N/A
information
--- --------------------- ----------------------------------------
e) Date of the 16 May 2018
transaction
--- --------------------- ----------------------------------------
f) Place of the London Stock Exchange (XLON)
transaction
--- --------------------- ----------------------------------------
Bryan Hotston
1 Details of the person discharging managerial
responsibilities / person closely associated
--- ---------------------------------------------------------------
a) Name Bryan Hotston
--- --------------------- ----------------------------------------
2 Reason for the notification
--- ---------------------------------------------------------------
a) Position/status PDMR
--- --------------------- ----------------------------------------
b) Initial notification Initial notification
/Amendment
--- --------------------- ----------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- ---------------------------------------------------------------
a) Name Hikma Pharmaceuticals PLC
--- --------------------- ----------------------------------------
b) LEI 549300BNS685UXH4JI75
--- --------------------- ----------------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date;
and (iv) each place where transactions have
been conducted
--- ---------------------------------------------------------------
a) Description Description: Ordinary shares of 10
of the financial pence each (Shares)
instrument, ID Code: GB00B0LCW083
type of instrument
and identification
code
--- --------------------- ----------------------------------------
b) Nature of Shares acquired from vesting of the
the transaction conditional awards on
16 May 2018 under the 2014 EIP Element
B.
--- --------------------- ----------------------------------------
c) Price(s) and Price(s): GBP13.18
volume(s) Volume(s): 1,860
--- --------------------- ----------------------------------------
d) Aggregated Volume: 1,860
information Price: GBP13.18
Total: GBP24,514.80
--- --------------------- ----------------------------------------
e) Date of the 16 May 2018
transaction
--- --------------------- ----------------------------------------
f) Place of the London Stock Exchange (XLON)
transaction
--- --------------------- ----------------------------------------
Peter Speirs
Company Secretary, responsible for releasing this
announcement
+44 (0) 20 7399 2760
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBDGDUCGBBGIR
(END) Dow Jones Newswires
May 17, 2018 08:10 ET (12:10 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024
